All individuals with SLF2 and SMC5 variants presented with a similar clinical phenotype, including marked microcephaly (−3.57 to −11.88 SD) and a reduction in height (-2.19 to -8.24 SD) (Fig. 1b; Supplementary Data 1). This evidence concerns the gene SMC5 and microcephaly.